<unk>  is a rare, autosomal dominant, hereditary disorder that predisposes carriers to cancer development. It was named after two American physicians, Frederick Pei Li and Joseph F.<unk> , Jr., who first recognized the syndrome after reviewing the medical records and death certificates of 648 childhood rhabdomyosarcoma patients. This syndrome is also known as the sarcoma, breast, leukaemia and adrenal gland (SBLA) syndrome. The syndrome is linked to germline mutations of the p53 tumor suppressor gene, which encodes a transcription factor (p53) that normally regulates the cell cycle and prevents genomic mutations. The mutations can be inherited, or can arise from mutations early in embryogenesis, or in one of the parent's germ cells.
Li–Fraumeni syndrome
Simpson–Golabi–Behmel syndrome
Weismann-Netter–Stuhl syndrome
Smith–Lemli–Opitz syndrome
Wilson–Turner syndrome
Smith–Magenis syndrome
Ellis–Van Creveld syndrome
Rabson–Mendenhall syndrome